CN Stock MarketDetailed Quotes

Hunan Er-kang Pharmaceutical (300267)

Watchlist
  • 3.30
  • -0.05-1.49%
Market Closed Jun 30 15:00 CST
6.81BMarket Cap-17.28P/E (TTM)

Hunan Er-kang Pharmaceutical (300267) Key Financial Indicators

300267 Earnings per Share (EPS)

According to the latest financial report of Hunan Er-kang Pharmaceutical, the latest earnings per share (TTM) for the company is 0.01. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative

Loading...

300267 Book Value Per Share (BVPS)

Analyzing a company's fundamentals? Check out Hunan Er-kang Pharmaceutical's latest financial report to see how much their book value per share (BVPS) is currently at 1.95.

Currency: CNY

Cumulative

Loading...

300267 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Hunan Er-kang Pharmaceutical shows that the company's current ratio is 2.09, indicating healthy liquidity.

Currency: CNY

Cumulative

Loading...

300267 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Hunan Er-kang Pharmaceutical, the quick ratio is 1.52, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative

Loading...

300267 Return on Equity (ROE)

Want to learn more about the financial health of Hunan Er-kang Pharmaceutical? The latest ROE figure is 0.33%, indicating that the company has stable profitability.

Currency: CNY

Cumulative

Loading...

300267 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Hunan Er-kang Pharmaceutical, the total asset return on investment (ROA) is 0.19%.

Currency: CNY

Cumulative

Loading...

300267 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Hunan Er-kang Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 28.43%.

Currency: CNY

Cumulative

Loading...

300267 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Hunan Er-kang Pharmaceutical, the net profit margin is 3.81%, which is a good sign for its profitability.

Currency: CNY

Cumulative

Loading...

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran 'Doha talks' have devolved into a war of words! Trump took to social media to loudly proclaim that Iran had proactively sought Show More